Gosselies, Belgium – Évry, France July 9th, 2020
This transaction would bring together OncoDNA’s expertise in oncology precision medicine and IntegraGen’s know-how in DNA sequencing services and bioinformatics analyses. The combination of both companies would enable to offer a complete solution that combines oncology laboratory testing and software solutions which will benefit the treatment of patients with advanced cancer.
Poster
Clinical validation on the PAOLA-1/ENGOT-ov25 cohort of HRD calculation performed with the OncoDEEP® Kit comprehensive genomic panel.
The PAOLA-1/ENGOT-ov25 cohort is a pivotal clinical trial investigating maintenance therapy with olaparib and bevacizumab in patients with advanced ovarian cancer. A key outcome of the study is the significantly improved progression-free survival observed in...
